ROCHESTER, N.Y., April 4 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. , a leading developer of image-related biomarker solutions, announced today announced today that it has been invited to participate in Bio 2006, April 9 - 12 in Chicago, Illinois. Bio 2006 is the world's largest international gathering of biotechnology professionals from the pharmaceutical and biotechnology industry, as well as many other sectors of industry, government, educational and health care institutions.
VirtualScopics will be hosted by Greater Rochester Enterprise (GRE) in its exhibit booth within the New York State Pavilion. GRE (www.rochesterbiz.com/GRE/) is a public-private partnership established to professionally market the Rochester, NY metropolitan region as a competitive, high-profile place for business relocation and growth.
"VirtualScopics was chosen to represent the Rochester area as one of a number of newer, innovative companies serving the biotech and life sciences area that have started and are prospering in Rochester," said Dennis Mullen, interim president and CEO, Greater Rochester Enterprise.
"VirtualScopics is excited that GRE chose us to showcase the dynamic growth of the biotech and life sciences industry in the Rochester region," said Bob Klimasewski, president and CEO of VirtualScopics. "Our technology is being utilized by over a dozen of the world's pharmaceutical, biotech and medical device companies worldwide to bring new products to market faster. Bio 2006 provides us with an excellent opportunity to reinforce our position with existing customers, as well as reach out to new companies."
About VirtualScopics, Inc.
VirtualScopics, Inc. is a provider of advanced medical image analysis services. The company evolved from research first carried out at the University of Rochester Medical Center and School of Engineering. VirtualScopics has created a suite of image analysis tools used in detecting and analyzing specific structures in volumetric medical images, as well as characterizing minute changes in structures over time, providing vital information to support clinical trials and diagnostic applications. The firm's proprietary software algorithms can assemble hundreds of separate medical images taken during an MRI session into a single, three-dimensional model, bringing a new and previously unobtainable source of data to clinical researchers. For more information about VirtualScopics, visit www.virtualscopics.com.
Forward-Looking Statements
The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbors created thereby. Forward-looking statements deal with the Company's current plans, intentions, beliefs and expectations. Investors are cautioned that all forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed from time to time in reports filed by the Company with the Securities and Exchange Commission.
CONTACT: Tracy Bagatelle-Black Bagatelle-Black Public Relations 661/263-1842 tracy@bagatelleblack.com
VirtualScopics, Inc.CONTACT: Tracy Bagatelle-Black of Bagatelle-Black Public Relations forVirtualScopics, Inc., +1-661-263-1842, or tracy@bagatelleblack.com
